Fluoride aggravation of oxidative stress in patients with chronic renal failure

Fluoride

Volumn 39, Issue 4, 2006, Pages 302-309

  Bober, Joanna ^a,b   Kwiatkowska, Ewa ^a,b   Kȩdzierska, Karolina ^a,b   Olszewska, Maria ^a,b   Stachowska, Ewa ^a,b   Ciechanowski, Kazimierz ^a,b   Chlubek, Dariusz ^a,b  

^a Pomeranian Medical University ^*

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Chronic Renal Failure; Fluoride stress; Glutathione peroxidase; Haemodialysis; Plasma copper; Plasma selenium; Plasma zinc; Superoxide dismutase; Thiobarbituric Acid Reactive Substances

Indexed keywords

COPPER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORIDE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID; ZINC;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEMODIALYSIS; HUMAN; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS;

EID: 33846619286     PISSN: 00154725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Spencer H, Kramer L, Gatza C, Morris C, Wiatrowski E, Gandhi VC. Fluoride metabolism in patients with chronic renal failure. Arch Intern Med 1980;140(10):1331-5.
2. Schiffl HH, Binswanger U. Human urinary fluoride excretion as influenced by renal functional impairment. Nephron 1980;26(2):69-72.
3. Canturk NZ, Undar L, Ozbilum B, Canturk M, Yalin R. The influence of hemodialysis on plasma fluoride. Mater Medica Polona 1992;24(2):89-90.
4. Turner CH, Owan I, Brizendine EJ, Zhang W, Wilson ME, Dunipace AJ. High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency. Bone 1996;19(6):595-601.
5. Ekstrand J, Ehmebo M, Whitford GM, Jarnberg PO. Fluoride pharmacokinetics during acid-base balance changes in man. Eur J Clin Pharmacol 1980;8(2):189-94.
6. Chaleil D, Simon P, Tessier B, Cartier F, Allain P. Blood plasma fluoride in haemodialysed patients. Clin Chim Acta 1986;156(1):105-8.
7. Tanimura Y. Studies on serum fluoride and bone metabolism in patients with long-term hemodialysis. Bull Osaka Med Coll 1994;40:65-72.
8. Nicolay A, Bertocchio P, Bargas E, Reynier J-P. Long term follow up of ionic plasma fluoride level in patients receiving hemodialysis treatment. Clin Chim Acta 1997;263:97-104.
9. Usuda K, Kono K, Yoshida Y. Clearance of fluoride by hemodialysis. Clin Nephrol 1996;45:363-4.
10. Usuda K, Kono K, Yoshida Y. The effect of hemodialysis upon serum levels of fluoride. Nephron 1997;75:175-8.
11. Whitford GM. The physical and toxicological characteristics of fluoride. J Dental Res 1990;69:539-49.
12. Nicolay A, Bertocchio P, Bargas E, Coudore F, Al Chahin G, Reynier J-P. Investigation of fluoride elimination during a dialysis session. Clin Chim Acta 1998;275:19-26.
13. Bland LA, Arnow PM, Arduino MJ, Bova J, McAllister S. Potential hazards of deionization system used for water purification in hemodialysis. Artificial Organs 1995;20:2-7.
14. Nicolay A, Bertocchio P, Bargas E, Coudore F, Al Chahin G, Reynier J-P: Hyperkalemia risks in hemodialysed patients consuming fluoride-rich water. Clin Chim Acta 1999;281:29-36.
15. Pettifor JM, Schnitzler CM, Ross FP, Moodley GP. Endemic skeletal fluorosis in children: hypocalcemia and the presence of renal resistance to parathyroid hormone. Bone Miner 1989;7(3):275-88.
16. Gerster JC, Charhon SA, Jaeger P, Boivin G, Briancon D, Rostan A, Baud CA, Meunier PJ. Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. Br Med J 1983;287(6394):723-5.
17. Arnow PM, Bland LA, Garcia-Houchins S, Fridkin S, Fellner SK. An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit. Ann Intern Med 1994;121:339-44.
18. Gessner BD, Beller M, Middaugh JP, Whitford GM. Acute fluoride poisoning from a public water system. N Engl J Med 1994;330(2):95-9.
19. Chlubek D, Stachowska E, Bober J. Effect of fluoride ions on the free radical reactions and antioxidative enzymes activity. Bromat Chem Toksykol 2001;34(3):263-6. [in Polish].
20. Iseki K, Kawazoe N, Fukijama K. Serum albumin is a strong predicates of death in chronic dialysis patients. Kidney Int 1993;44:115-9.
21. Soejima A, Matsuzawa N, Miyake N, Karube M, Fukuoka K, Nakabayashi K, et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol 1999;51:92-7.
22. Lin TH, Chen JG, Liaw JM, Juang JG. Trace elements and lipid peroxidation in uremic patients on hemodialysis. Biol Trace Elem Res 1996;51:277-83.
23. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, et al. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991;57:10-5.
24. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-6.
25. Wendel A. Glutathione peroxidase. Methods Enzymol 1981;77:325-33.
26. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
27. Danch A, Drozdz M. A simplified technique of fluorometric selenium assay in biological material. Diagn Lab 1996;32:529-34. [in Polish].
28. Moskwa A, Walczak A, Mikulski T. Serum calcium, magnesium and fluoride concentrations in schizophrenics patients. Met Fluor 1998;8:83-8. [in Polish].
29. Usuda K, Kono K, Watanabe T, Dote T, Shimizu H, Tominaga M, et al. Hemodialyzability of ionizable fluoride in hemodialysis session. Sci Total Environ 2002;297(1-3):183-91.
30. al-Wakeel JS, Mitwalli AH, Huraib S, al-Mohaya S, Abu-Aisha H, Chaudhary AR, et al. Serum ionic fluoride levels in haemodialysis and continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 1997;12(7):1420-4.
31. Shivarajashankara YM, Shivashankara AR, Bhat PG, Rao SH. Lipid peroxidation and antioxidant systems in the blood of young rats subjected to chronic fluoride toxicity. Indian J Exp Biol 2003;41(8):857-60.
32. Aydin G, Cicek E, Akdogan M, Gokalp O. Histopathological and biochemical changes in lung tissues of rats following administration of fluoride over several generations. J Appl Toxicol 2003;23(6):437-46.
33. Guan ZZ, Xiao KQ, Zeng XY, Long YG, Cheng YH, Jiang SF, et al. Changed cellular membrane lipid composition and lipid peroxidation of kidney in rats with chronic fluorosis. Arch Toxicol 2000;74(10):602-8.
34. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopteezna-Grzebieniak E. Effect of hemodialysis on lipid peroxidation and antioxidatant system in patients with chronic renal failure. Metabolism 1992;41:1229-32.
35. Canestrari F, Galli F, Giorgini A, Albertini MC, Galiotta P, Pascucci M, et al. Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of gluthatione metabolism. Acta Haemat 1994;91:187-93.
36. Mimic-Oka J, Simic T, Ekmescic V, Dragicevic P. Erythrocyte gluthatione peroxidase and superoxidase dismutase activities in different stages of chronical renal failure. Clin Nephrol 1995;44:44-8.
37. Shivarajashankara YM, Shivashankara AR, Gopalakrishna Bhat P, Hanumath Rao S. Effect of fluoride intoxication on lipid peroxidation and antioxidant system in rats. Fluoride 2001;34(2):108-13.
38. Reddy GB, Khandare AL, Reddy PY, Rao GS, Balakrishna N, Srivalli I. Antioxidant defense system and lipid peroxidation in patients with skeletal fluorosis and in fluoride-intoxicated rabbits. Toxicol Sci 2003;72:363-8.
39. D'Haese PC, DeBroem E. Adequacy of dialysis: trace elements in dialysis fluids. Nephrol Dial Transplant 1996;11(suppl.2):92-7.
40. Kanwar KC, Singh M. Zinc, copper and manganese levels in various tissues following fluoride administration. Experientia 1981;37(12):1328-9.
41. Banci L, Bertini I, Luchinat C, Scozzafava A, Turano P. Binding of fluoride to copper zinc superoxide dismutase. Inorganic Chemistry 1989;28:2377-81.
42. Krechniak J, Inkielwewicz I. Correlations between fluoride concentrations and free radical parameters in soft tissues of rats. Fluoride 2005;38(4):293-6.
43. Zima T, Tesar V, Mestek O, Nemecek K. Trace elements in end-stage renal disease. 2. Clinical implication of trace elements. Blood Purif 1999;17(4):187-98.
44. Cappelli G, Inguaggiato P, Ferramosca E, Albertazzi A. Water treatment for hemodialysis. Contrib Nephrol 2002;137:317-24.
45. Bober J. Erythrocyte sodium-proton exchanger activity and oxidative stress in patients with chronic renal failure treated conservatively or with hemodialysis. Habilitation thesis. Ann Acad Med Stetin 2003;Suppl 90:1-80.